Clofutriben

N/A

Report date: 2026/02/14 20:00:22
NME

Base Information

Drug NameClofutriben
Drug Alias NameASP-3662SPI-62
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsCushing SyndromeObesityDiabetes Mellitus, Type 2 +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSparrow Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSparrow Pharmaceuticals Inc
Inactive CompaniesAstellas Pharma Global Development Inc
Active IndicationsCushing SyndromeObesityDiabetes Mellitus, Type 2 +[6] 
Inactive IndicationsDiabetic NeuropathiesPituitary ACTH Hypersecretion

Other Information

ATC CodeN/A
Related LinksN/A